drugset
drugset / Trial / NCT00673933

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris

NCT00673933 ↗

Phase 2 Completed 20 enrolled Photocure
RandomizedParallel-groupDouble-blindTreatment

Summary

In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

Timeline

Start
2008-05
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule 8 % Topical

Indications

acne